Back to Search
MYRON CZUCZMAN, MD
MD
Internal Medicine Physician
NPI: 1669478053Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
169807(NY)
Research & Publications (20)
Acquirement of rituximab resistance in lymphoma cell lines is associated with both global CD20 gene and protein down-regulation regulated at the pretranscriptional and posttranscriptional levels.
PMID 18316581·Clin Cancer Res·2008
8-other
Sixth International Workshop on non-Hodgkin Lymphoma: 16-17 November 2007, Boston, USA.
PMID 18821427·Leuk Lymphoma·2008
8-other
Treatment-related myelodysplastic syndrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapy.
PMID 17709799·J Clin Oncol·2007
8-other
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901.
PMID 17325852·Leuk Lymphoma·2007
3-trial
Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab.
PMID 17064996·Leuk Lymphoma·2006
3-trial
Controversies in follicular lymphoma: "who, what, when, where, and why?" (not necessarily in that order!).
PMID 17124076·Hematology Am Soc Hematol Educ Program·2006
6-review
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma.
PMID 15994148·J Clin Oncol·2005
3-trial
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
PMID 15681517·J Clin Oncol·2005
3-trial
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
PMID 15483015·J Clin Oncol·2004
3-trial
The first International Workshop on Non-Hodgkin's Lymphoma: taking a close look at current issues and future developments.
PMID 15202518·Leuk Lymphoma·2003
6-review
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
PMID 11842387·Semin Oncol·2002
6-review
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy.
PMID 11249036·Ann Oncol·2001
3-trial
Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.
PMID 19479618·Leuk Lymphoma·2009
3-trial
Dacetuzumab, a humanized mAb against CD40 for the treatment of hematological malignancies.
PMID 19513947·Curr Opin Investig Drugs·2009
7-preclinical
Therapeutic options in relapsed or refractory diffuse large B-cell lymphoma. Part 1. current treatment approaches.
PMID 19544696·Oncology (Williston Park)·2009
6-review
Therapeutic options in relapsed or refractory diffuse large B-cell lymphoma. Part 2. Novel therapeutic strategies.
PMID 19626827·Oncology (Williston Park)·2009
6-review
NCCN task force report: molecular markers in leukemias and lymphomas.
PMID 19635230·J Natl Compr Canc Netw·2009
6-review
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.
PMID 19380866·Blood·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- ELM AND CARLTON ST
BUFFALO, NY 14263 - Phone
- (716) 845-2300
Quick Facts
- NPI
- 1669478053
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile